- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/113 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/113
Total number of patents in this class: 290
10-year publication summary
|
26
|
26
|
30
|
22
|
18
|
18
|
18
|
30
|
18
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1844 |
27 |
| King Faisal University | 933 |
16 |
| Bayer AG | 3501 |
10 |
| BASF SE | 21303 |
9 |
| Cytokinetics, Inc. | 251 |
8 |
| Syngenta Crop Protection AG | 6701 |
7 |
| Abbvie Inc. | 1836 |
6 |
| Calico Life Sciences LLC | 111 |
6 |
| Bayer Intellectual Property GmbH | 2364 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| The General Hospital Corporation | 4870 |
4 |
| Northwestern University | 3543 |
4 |
| Cedars-Sinai Medical Center | 1203 |
4 |
| Denali Therapeutics Inc. | 272 |
4 |
| Romark Laboratories L.C. | 44 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
4 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 223 |
4 |
| Novartis AG | 10262 |
3 |
| Syngenta Participations AG | 1524 |
3 |
| Purdue Research Foundation | 3916 |
3 |
| Other owners | 154 |